Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.

Noriyuki OkonogiHirokazu UsuiKazutoshi MurataMakoto HoriTomoya KurokawaTadami FujiwaraYasuhisa FujiiMichiko HanawaYohei KawasakiYoko HattoriKazuko SuzukiKyoko TsuyukiMasaru WakatsukiSumitaka HasegawaShigeru YamadaHideki HanaokaMakio ShozuHiroshi Tsuji

Published in: BMJ open (2022)

Japan Registry of Clinical Trials (jRCT2031210083), registered on 12 May 2021.

Keyphrases

clinical trial
locally advanced
open label
squamous cell carcinoma
early stage
randomized controlled trial
rectal cancer
neoadjuvant chemotherapy
phase ii study